HMOX1 and COVID-19: Both serum HO-1 and sCD163 levels were higher in COVID-19 patients than in healthy volunteers (median HO-1: 27.5 ng/mL vs. 2.9 ng/mL (P < 0.001), median sCD163 615.0 ng/mL vs. 368.5 ng/mL (P < 0.001)).